365 related articles for article (PubMed ID: 37655228)
1. Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies.
Sills GJ
Ther Adv Neurol Disord; 2023; 16():17562864231191000. PubMed ID: 37655228
[TBL] [Abstract][Full Text] [Related]
2. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2022 Oct; 36(10):1079-1111. PubMed ID: 36194365
[TBL] [Abstract][Full Text] [Related]
3. Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes.
Frampton JE
Drugs; 2023 Jul; 83(10):923-934. PubMed ID: 37316680
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis.
Wu J; Zhang L; Zhou X; Wang J; Zheng X; Hu H; Wu D
Front Pharmacol; 2022; 13():980937. PubMed ID: 36120377
[No Abstract] [Full Text] [Related]
5. Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox-Gastaut syndrome in clinical practice.
Wirrell EC; Lagae L; Scheffer IE; Cross JH; Specchio N; Strzelczyk A
Epilepsia Open; 2024 Jul; ():. PubMed ID: 38962968
[TBL] [Abstract][Full Text] [Related]
6. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2022 Mar; 36(3):217-237. PubMed ID: 35156171
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
[TBL] [Abstract][Full Text] [Related]
8. An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies.
Martin P; Reeder T; Sourbron J; de Witte PAM; Gammaitoni AR; Galer BS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445144
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Lattanzi S; Trinka E; Russo E; Del Giovane C; Matricardi S; Meletti S; Striano P; Damavandi PT; Silvestrini M; Brigo F
Drugs; 2023 Oct; 83(15):1409-1424. PubMed ID: 37695433
[TBL] [Abstract][Full Text] [Related]
10. Stiripentol for the treatment of seizures associated with Dravet syndrome.
Chiron C
Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478
[TBL] [Abstract][Full Text] [Related]
11. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
12. The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results.
Johannessen Landmark C; Potschka H; Auvin S; Wilmshurst JM; Johannessen SI; Kasteleijn-Nolst Trenité D; Wirrell EC
Epilepsia; 2021 Apr; 62(4):857-873. PubMed ID: 33638459
[TBL] [Abstract][Full Text] [Related]
13. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic advances in Dravet syndrome: a targeted literature review.
Strzelczyk A; Schubert-Bast S
Expert Rev Neurother; 2020 Oct; 20(10):1065-1079. PubMed ID: 32799683
[TBL] [Abstract][Full Text] [Related]
15. Interaction of cannabidiol with other antiseizure medications: A narrative review.
Gilmartin CGS; Dowd Z; Parker APJ; Harijan P
Seizure; 2021 Mar; 86():189-196. PubMed ID: 33541771
[TBL] [Abstract][Full Text] [Related]
16. Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.
Lattanzi S; Zaccara G; Russo E; La Neve A; Lodi MAM; Striano P
Expert Rev Neurother; 2021 Jan; 21(1):99-110. PubMed ID: 33026899
[TBL] [Abstract][Full Text] [Related]
17. Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.
Buck ML; Goodkin HP
Ann Pharmacother; 2019 Nov; 53(11):1136-1144. PubMed ID: 31167540
[No Abstract] [Full Text] [Related]
18. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
19. New and emerging pharmacologic treatments for developmental and epileptic encephalopathies.
Vasquez A; Buraniqi E; Wirrell EC
Curr Opin Neurol; 2022 Apr; 35(2):145-154. PubMed ID: 35102126
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]